SCHEMBL242136

SCHEMBL242136

CCP(=O)(O)ON

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3692263 0.78
SCHEMBL29220014 0.76
SCHEMBL6562094 0.75 PPARD (0.46)
SCHEMBL4087711 0.74
Alcohol SCHEMBL5089814 0.73
SCHEMBL28063817 0.73 PPARD (0.44)
SCHEMBL2100459 0.73
SCHEMBL1291624 0.73
SCHEMBL18686716 0.73 PPARD (0.44)
SCHEMBL29252977 0.72 PPARD (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119143096-A Calcium carbonate/calcium phosphate composite hollow nanosphere and preparation method and application thereof 西安交通大学 2024-12-17 CN claimed
CN-109317117-B Magnetic adsorbent, preparation method thereof and method for treating actinide waste liquid 中国工程物理研究院核物理与化学研究所 2021-08-31 CN claimed
CN-111498866-A Organic hybrid-C L O structure silicoaluminophosphate molecular sieve and preparation method thereof 北京化工大学 2020-08-07 CN claimed
CN-111333083-A Organic hybrid-CLO structure aluminum phosphate molecular sieve and preparation method thereof 北京化工大学 2020-06-26 CN claimed
US-20140227201-A1 Antimicrobial Gel Formulations NOVABAY PHARMACEUTICALS, INC. 2014-08-14 US claimed
CN-103589418-A Preparation method of water-soluble upconversion fluorescent nano material GUANGZHOU IMPROVE MEDICAL TECHNOLOGY CO LTD 2014-02-19 CN claimed
CN-103487418-A Method for detecting upconversion fluorescence resonance energy transfer by using carbon nanomaterial as receptor GUANGZHOU IMPROVE MEDICAL TECHNOLOGY CO LTD 2014-01-01 CN claimed
CN-103468266-A Preparation method of water-soluble upconversion fluorescence nano material GUANGZHOU IMPROVE MEDICAL TECHNOLOGY CO LTD 2013-12-25 CN claimed
CN-102970972-A Use of nitrocarboxylic acids for the treatment, diagnosis and prevention of aggressive healing patterns DIETZ ULRICH 2013-03-13 CN claimed
JP-2012500209-A 2012-01-05 JP claimed
EP-1334175-B1 IMPROVEMENTS IN OR RELATING TO SELECTIVE AGENTS FOR BIOLOGICAL CULTURES OXOID LTD (GB) 2009-12-23 EP claimed
WO-2009126912-A1 COMPOSITIONS COMPRISING N-HALOGENATED OR N, N-DIHALOGENATED AMINE FOR TREATMENT AND PROPHYLAXIS OF BRONCHOPULMONARY INFECTIONS NOVABAY PHARMACEUTICALS, INC. (US) 2009-10-15 WO claimed
WO-2005067939-A1 THERAPEUTICALLY USEFUL ANTIBACTERIAL COMPOUNDS OXOID LIMITED (GB) 2005-07-28 WO claimed
US-20040048778-A1 Selective growth media OXOID LIMITED (GB) 2004-03-11 US claimed
CN-1137886-C 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives ��˹��ŵ�� 2004-02-11 CN claimed
EP-1334175-A1 IMPROVEMENTS IN OR RELATING TO SELECTIVE AGENTS FOR BIOLOGICAL CULTURES Oxoid Limited (GB) 2003-08-13 EP claimed
WO-2002022785-A1 IMPROVEMENTS IN OR RELATING TO SELECTIVE AGENTS FOR BIOLOGICAL CULTURES OXOID LIMITED (GB) 2002-03-21 WO claimed
EP-0753551-B1 Ink set and process for alleviating bleed in printed elements DU PONT (US) 2000-02-09 EP claimed
US-5750594-A Ink set and process for alleviating bleed in printed elements E. I. DU PONT DE NEMOURS AND COMPANY (US) 1998-05-12 US claimed
EP-0753551-A2 Ink set and process for alleviating bleed in printed elements E.I. DU PONT DE NEMOURS AND COMPANY (US) 1997-01-15 EP claimed